U.S. approves Pfizer-BioNTech vaccine for children aged 5-11
The U.S. has approved the Pfizer-BioNTech vaccine for children aged five to 11. The U.S. Centers for Disease Control and Prevention on Tuesday recommended the shot for broad use in that age group after a panel of outside advisers voted in favor of it. For more: https://www.cgtn.com/video Subscribe to us on YouTube: https://goo.gl/lP12gA Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8 Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv